Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)

Clinical trial NCT05598528 · RECRUITING

Trial details

NCT number: NCT05598528
Sponsor: Second Xiangya Hospital of Central South University
Status: RECRUITING
Study type: OBSERVATIONAL

Lung Cancer, Non-small Cell EGFR Gene Mutation EGFR-TKI Resistant Mutation Primary Resistance Circulating Tumor DNA

Start date: 2021-09-28
Primary completion: 2025-12-31
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.